selected publications
-
Journal Article
- Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement. Brain and behavior. 2020
- Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease. Neuroscience Letters. 2020
- Intranasal coadministration of a diazepam prodrug with a converting enzyme results in rapid absorption of diazepam in rats. Journal of Pharmacology and Experimental Therapeutics. 2019
- Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease. Journal of the Neurological Sciences. 2017
- Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinsons disease. Brain Research. 2014
- Intranasal administration of CNS therapeutics to awake mice. Journal of visualized experiments. 2013
- Value and limitations of transpulmonary pressure calculations during intra-abdominal hypertension. Critical Care Medicine. 2013
- Experimental intra-abdominal hypertension attenuates the benefit of positive end-expiratory pressure in ventilating effusion-compressed lungs*. Critical Care Medicine. 2012
-
Conference Poster